How Digital Health Startups Scale

Scaling DTC in digital health takes more than ad spend. We architect acquisition systems end-to-end—from segmentation and creative frameworks to pricing, onboarding, and checkout UX—so the right patients convert with less friction.

Our operators continuously test and tune channels, discover profitable micro-segments, and systematize wins. The result is faster growth, lower CAC, and durable market share gains.

LTV in health is driven by outcomes and ongoing engagement. We blend clinical insight with consumer analytics to optimize onboarding, reduce churn, and create habit-forming product experiences.

Through lifecycle messaging, personalized interventions, and value-add programs, we convert one-time purchasers into long-term relationships—stabilizing revenue and increasing valuation multiples.

Digital health narratives are complex. We translate features into human impact supported by data and social proof, then deploy across paid, owned, and earned channels.

Our creative + analytics loop finds message-market fit fast and compounds it, improving conversion at every stage of the funnel without wasted spend.

Healthcare buying is multi-threaded. We equip clinical champions, benefits leaders, and finance with the precise clinical, operational, and economic case each needs to say “yes.”

Our playbooks neutralize procurement friction, structure risk-sharing when useful, and align incentives—converting interest into multi-site contracts.

We bridge the gap between contracted coverage and real-world use through omnichannel campaigns—member education, provider co-marketing, community partnerships, and SMS/app nudges.

The payoff: higher activation and sustained engagement that demonstrate measurable ROI to payers and employers, reinforcing expansion decisions.

Momentum stalls when teams underestimate regulation and coding. We map the right pathway, align claims/evidence with reimbursement logic, and prepare teams for audits and reviews.

This de-risks commercialization and accelerates payer traction, so regulatory success translates directly into scalable adoption.

We help design, launch, and leverage clinical studies and economic analyses that demonstrate patient impact and financial value in the settings that matter.

We then translate results into compelling collateral—obs dashboards, one-pagers, and contract-ready evidence—so enterprise buyers can act with confidence.

Capital efficiency and credibility matter. We align strategy, metrics, and milestones with what top investors and strategic partners need to underwrite.

Our guidance raises the quality of the narrative and the plan, improving win rates in the room and creating optionality for the next stage of growth.